studying the effect of different uterotonic agents in prevention of postpartum hemorrhage following cesarean section in high risk cases.

Phase 3

Completed

• Conditions: Postpartum hemorrhage following cesarean section; Surgery - Other surgery; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12615000546550
• Lead Sponsor: Sherine Hosny Mohamed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 240

Inclusion Criteria

pregnant full term women that are scheduled to undergo ceserean section and have at least ONE of following (high risk patients for PPH) .
1. Past history of PPH.
2. Antepartum hemorrhage (eg placenta previa and accidental
hemorrhage.
3. Over distension of the uterus (polyhydraminos, multiple pregnancy and macrosomia.
4. Intra-amniotic infection.
5. Uterine muscle exhaustion (prolonged labour and high parity).
6. Anatomical uterine anomalies and uterine fibroid.

Exclusion Criteria

Medical disorders with pregnancy eg hypertensive disorder, Diabetes Mellitus, serious cardiovascular disorders, migraine ,epilepsy, asthma etc…

Study & Design

• Study Type: Interventional
• Study Design: Not specified